China SXT Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2017 | 64.0% | 64.0% | — |
| FY2018 | 36.1% | 36.1% | 15.5% |
| FY2019 | 13.9% | 13.8% | 8.8% |
| FY2020 | -109.4% | -109.0% | -47.4% |
| FY2021 | -17.2% | -17.2% | -8.0% |
| FY2022 | -35.7% | -35.7% | -17.1% |
| FY2023 | -40.4% | -40.1% | -20.1% |
| FY2024 | -22.2% | -22.1% | -13.4% |
| FY2025 | -21.4% | -21.3% | -15.2% |
| FY2026 | -20.9% | -20.4% | -17.9% |